Archean Chemical Industries Limited has scheduled a meeting with analysts and institutional investors on June 8, 2026, in Mumbai. The interaction is part of the ICICI Securities India Investor Conference titled 'India Rising: The Next Chapter'. The company stated that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) will be shared during the session.

The company disclosed this event pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In its filing, Archean Chemical Industries noted that it had inadvertently missed notifying the stock exchanges about its participation in the conference in a timely manner. The management requested the exchanges to condone the delay and assured stakeholders of greater vigilance in future filings.

The meeting is scheduled to begin at 10:00 am onwards and will be held in a 1x1 or group format. The company also indicated that changes to the schedule might occur due to exigencies on the part of the participants or the company.

Meeting Details

The information regarding the conference has been made available on the company's official website.

Archean Chemical Industries Limited has commenced the subscription process to invest up to Rs 170 crore in its wholly owned subsidiary, Acume Chemicals Private Limited, through a rights issue. The Board of Directors approved this investment on May 11, 2026, to strengthen the capital base of the subsidiary and support its future business expansion. The funds will be utilized to improve capacity utilisation, enhance product mix, and reduce external borrowings, thereby strengthening the balance sheet of Acume Chemicals.

The company will subscribe to equity shares of Acume Chemicals in one or more tranches, with the total investment not exceeding Rs 170,00,00,000. The subscription is proposed to be completed within one month from the date of the rights offer. The transaction constitutes a related party transaction as Acume Chemicals is a wholly owned subsidiary, and the subscription is being undertaken on a rights basis proportionate to the company's existing shareholding. The consideration for the acquisition will be in cash, with shares subscribed at a face value of Rs 10 per share.

Acume Chemicals Private Limited, incorporated on November 18, 2021, operates in the chemical industry, specifically in the Bromine Derivatives business. As of March 31, 2026, the subsidiary reported total assets of Rs 28,649.78 lakh and revenue from operations of Rs 8,111.53 lakh. The company holds 100% of the equity share capital of Acume Chemicals and will maintain this ownership level post-subscription. No separate governmental or regulatory approvals are presently required for the investment, which will be conducted in accordance with the Companies Act, 2013.

Financial Performance of Acume Chemicals

The subsidiary has demonstrated significant growth in turnover over the past three years. The following table details the financial performance of Acume Chemicals:

Key Details of the Investment